(Manager Magazin) Asklepios want to buy in large scale (google Transl.)

Good one billion euros will spend on acquisitions of sole shareholder of Asklepios Hospital Group. On the list of Bernard gr. Broer man, parts of the Rhön-Klinikum-group, the median group or hospitals in Leipzig.
Hamburg - The private hospital group Asklepios plans to purchase various hospital chains. As the manager magazine in its latest issue (release date: August 22). Reported sole shareholder Bernard gr Broer man wants to take over hospitals for at least one billion euros.
He is particularly interested in the remains of the Rhön-Klinikum Group, which still accounts for around one billion euros in sales after the sale of 40 houses at Fresenius. High on his list are next to the median group, a chain of rehabilitation hospitals with 500 million sales, as well as two hospitals in Leipzig with about 100 million euros in sales.
Even a home in the beautiful clinic with 640 million euros in sales and the two billion euro revenue strong Sana chain can imagine Asklepios. Since the clinic group was only moderately indebted, it could take around one billion euros of debt in the capital markets currently, cited the manager magazin senior bankers.

(BFW) Electrabel Says Premature to Draw Conclusions From Reactor Tests

Could be interesting to look to Buy GSZ Sell EDF

{GSZ FP Equity EDF FP Equity GRT D}


BN 08/21 12:51 *ELECTRABEL TO SPLIT UP TIHANGE-1'S 10-YEAR OVERHAUL
BN 08/21 12:50 *ELECTRABEL SAYS DOEL-3, TIHANGE-2 TESTS MAKING GOOD PROGRESS
BN 08/21 12:49 *ELECTRABEL SAYS PREMATURE TO DRAW CONCLUSIONS FROM NUCLEAR TEST

Electrabel Says Premature to Draw Conclusions From Reactor Tests
2014-08-21 12:56:41.720 GMT


By John Martens
Aug. 21 (Bloomberg) -- GDF Suez subsidiary repeats final
test results on Doel 3, Tihange 2 reactor vessels will be sent
to Belgian nuclear regulator in autumn, according to e-mail.
* Electrabel to split up 10-yr overhaul schedule of Tihange 1,
with 1st phase due Aug. 30 - Oct. 16 and 2nd phase due June
6 - July 31, 2015, to ensure availability in winter months
* NOTE: Yday: Belgian Doel 3, Tihange 2 May Be Offline Through
Winter: VRT: {NSN NALBN96JIJV0 <go>}
* NOTE: June 12: Electrabel Says Doel 3, Tihange 2 Tests to
Run Until Autumn: {NSN N72D4P6K50XU <go>}

Link to Company News:{GSZ FP <Equity> CN <GO>}

For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}

To contact the editor responsible for this story:
John Martens at +32-2-285-4303 or
jmartens1@bloomberg.net

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
: SMTC +6.8%, HRL +2%, NM +1.3%, ASM +0.5%, CACI +0.3%.

M&A news: ACT +1.9% (may be a possible takeover target following ending of Pfizer (PFE) and Asterzenca (AZN) takeover talks, according to reports), VMW +1.1% (announced the acquisition of CloudVolumes, a provider of real-time application delivery technology).

Select phrama/biotech related names showing strength: AZN +2.4% (rumored interest in ACT), EXAS +1.4%, SNY +1%, CELG +1%.

Select semi names showing strength: SMTC +6.8%, STM +1.7%, ASML +1.2%.

Other news: UNTK +8.8% (common stock to begin trading on the OTC), DGLY +8.1% (recent momentum body camera play), TKMR +4.6% (seeing early strength; NYTimes positive on experimental drug for ebola-like virus), AUXL +4.5% (announces positive data from Phase 2a study of CCH In patients with cellulite), BLRX +2.9% (announces receipt of Notice of Allowance from USPTO for a patent claiming the use of BL-7010), CPST +2.5% (still checking), HTZ +1.5% (following late move higher in Icahn stake news), PANW +1.3% (positive mention on Mad Money).

Analyst comments: PLAB +4.1% (upgraded to Buy from Hold at Needham), AEO +1.2% (upgraded to Buy at Janney, upgraded to Buy from Neutral at Sun Trust Rbsn Humphrey), ROSE +1.1% (upgraded to Accumulate from Hold at KLR Group), CRH +0.8% (upgraded to Mkt Perform from Underperform at Bernstein)

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
: SSI -9.5%, BONT -7.7%, WUBA -6.7%, KIRK -5.1%, SHLD -4.3%, PLKI -3.2%, GFI -1.9%, DLTR -0.6%, CYBX -0.5%.

M&A news: DG -1.3% (also, sends letter to Family Dollar's (FDO) Board of Directors), FDO -0.4% (CNBC's David Faber reporting Family Dollar will reject Dollar General's (DG) $78.50 bid for company shortly, due to antitrust risk).

Select metals/mining stocks trading lower: HMY -2.3%, PAAS -2.1%, IAG -2%, GOLD -1.7%, AU -1.1%, CDE -1.1%, ABX -0.9%, BHP -0.9%, SLW -0.9%, RIO -0.8%, EGO -0.7%, AUY -0.7%.

Other news: KIN -30.7% (announces its pivotal field study (KB010) of CereKin, an interleukin-1 inhibitor for the control of pain and inflammation associated with osteoarthritis in dogs, did not meet its primary endpoint ), MCC -3.1% (prices 5 mln shares of its common stock at a public offering price of $13.02 per share), KTOS -1.8% (filed for $300 mln mixed securities shelf offering), ITMN -1.1% (downgraded to Mkt Perform from Outperform at Wells Fargo), MAC -0.6% (filed mixed securities shelf offering).

Analyst comments
: CCJ -1.5% (downgraded to Market Perform at Cowen), WWAV -0.9% (downgraded to Neutral from Buy at Longbow), MSG -0.5% (downgraded to Hold from Buy at Stifel).

>>> US Early premarket gappers

Early premarket gappers

Gapping up: UNTK +8.8%, DLTR +4.6%, DLTR +4.6%, TKMR +4.1%, AZN +2.2%, SMTC +2.1%, SMTC +2.1%, EXAS +1.9%, NOK +1.8%, NM +1.3%, SAN +1.2%, CELG +1.1%, AEO +0.9%, SNY +0.9%, ASML +0.9%,

Gapping down: KIN -35%, SSI -12.2%, PLKI -4.3%, WUBA -4.1%, PAAS -1.9%, GOLD -1.7%, RGSE -1.6%, EGO -1.5%, SHLD -1.2%, AU -1.1%, ABX -1%, BHP -0.9%, RIO -0.8%,

>>> CNbC Mad money

Palo Alto Networks among stocks with favorable commentary on Wednesday's Mad Money

Stocks with favorable mention: ATVI, BA, BBY, BHP, CAB, DNOW, HAIN, PANW, PII, TTWO, UNP

Stocks with unfavorable mention: FEYE, HOG, HTZ, RTI, SWHC

WSJ : Yoga Poseurs: Athletic Gear Soars, Outpacing Sport Itself

The rate of growth in the U.S. retail athletic apparel market is surging, even as Americans' rate of participating in most sports is in decline.

The result is a phenomenon the apparel industry calls "athleisure"—a bright spot in a sluggish business thanks to Americans who are increasingly donning sneakers in the boardroom and yoga pants at brunch.

Analysts at Barclays estimate the U.S. athletic apparel market will increase by nearly 50% to more than $100 billion at retail by 2020, driven in large part by consumers snapping up stretchy tees and leggings that will never see the fluorescent lights of a gym.

Demand for yoga gear, for example, is outpacing growth of the sport itself. Yoga participation grew 4.5% in 2013, according to the Sports & Fitness Industry Association.

Meanwhile, sales of yoga apparel were up 45%, according to Matt Powell, an analyst for SportsOneSource, a sporting-goods industry tracker.

"Everyone is wearing yoga pants, even people who aren't doing it," said Karen Score, the owner of Yoga Mandali, an independent yoga store in Saratoga Springs, N.Y.

Ms. Score, who also runs an adjoining yoga studio, is drawing up brochures for fall classes with the tag line: "Do you wear yoga pants? Why not try yoga?"

Lauren Wheeler-Woodburn estimates that she owns at least 25 pairs of yoga pants.

As a graduate student at the University of Southern California and social-media strategist, she says she wears them mostly every day, for class or to work, or just sitting at home lounging.

"I sound like the yoga pants version of a crazy cat lady," said Ms. Wheeler-Woodburn, who prefers Lululemon but dons other brands too.

The 25-year-old isn't a diligent yogi, though she practices at home sometimes. For her, the clothing isn't an athletic utility but a wardrobe staple. Yoga pants, she said, are easy to clean, don't need to be ironed and, at $90 a pop at Lululemon, are cheaper and more versatile than even her favorite jeans, for which she pays upward of $200 a pair at Nordstrom.

The trend isn't limited to yoga. Organizers of a trade show for traditional outdoor and camping retailers earlier this month debuted a new exhibit devoted to so-called urban wear for "millennials" who wear their boots and flannels with no intention of actually hiking.

For men, retailers are rolling out new versions of jogger pants—sweatpant-like trousers with elastic cuffs at the ankles. Mr. Powell, of SportsOneSource, said they have been a main topic of discussion at apparel trade shows throughout Las Vegas this week.

Tracksmith, an online apparel boutique, made its debut in July offering preppy, $90 men's running shorts.

Not long afterward, a parody site called Running Team JVA mocked Tracksmith's marketing. "Running is free. But it shouldn't be," the site reads.

Matt Taylor, a co-founder of Tracksmith, which sold out its first shipment of inventory, said he thought the site was "pretty clever."

Betabrand, a San Francisco-based apparel startup that crowdsources ideas for items and crowdfunds the production, said the debut of its chino-styled dress-pant yoga pants earlier this year was so successful the company has put ideas for other projects on hold to focus on the athletic apparel business, particularly for women.

The Sports & Fitness Industry Association tracks participation rates across six categories. Over the past five years, participation in individual, racket and team sports fell, and was flat for outdoor, water and fitness sports.

Meanwhile, the size of the U.S. market for workout clothes grew by 5% a year on average, from roughly $54 billion to $68 billion, according to analysts at Barclays.

Athletic apparel manufacturers and retailers are reaping the benefits. Under Armour Inc., UA +0.63% once known largely for its compression gear worn by football players, expects its annual revenue to surge 29% this year to $2.91 billion, fueled by its expansion into women's wear, youth apparel and footwear.

Consumers "have and will continue to want versatility, to look great everywhere, in the gym, on the street, in class," said Henry Stafford, president of Under Armour North America.

Dick's Sporting Goods Inc., DKS +1.88% reeling from downturns in both the golf and hunting categories, said this week it is looking to grow its other businesses, and has already begun allocating more store space to sports apparel, particularly for women and children in time for back-to-school shopping. Bon-Ton Stores Inc. BONT -1.20% in May said it would "outsize the active athleisure category across all zones." Kohl's Corp. KSS +1.97% will begin selling flashy sweatpants by Juicy Couture in the fall as a means "to capture more of the athleisure market."

In March, Andy Mooney, chief executive of surf and snowboard apparel maker Quiksilver Inc., ZQK -2.20% said the company was de-emphasizing the core adventure-sports community and "going back to what we did when we first started, which is, we were both functional and fashionable at the same time."

The changes are even being noted in high-end markets. Online luxury apparel retailer Net-a-Porter in July unveiled a channel devoted exclusively to high-fashion athletic looks, named Net-a-Sporter.

Luxury brand Christian Dior CDI.FR +0.60% unveiled some sneaker-inspired pumps for its fall ready-to-wear line. A glazed rubber pointy-toed upper is paired with a rubber sole inspired by running shoes. The heels are available for preorder in Dior stores starting at $1,450.

The athletic apparel market isn't without its challenges. Lululemon Athletica Inc., LULU +0.03% which has been wrestling for a year-and-a-half with supply chain and quality issues, cut its outlook for the year as it works to clear excess inventory.

Alexandra Medina, of Costa Mesa, Calif., likes to wear yoga pants around town, which is standard fare in her community. She said she likes to work out, but can't always find the time in days that are consumed with running her flooring company and chasing her 19-month-old daughter.

"When you put on your workout apparel," she said, "you think, 'Huh, maybe I should think about working out today.' "

WSJ : Top U.K. Fund Manager Neil Woodford Says Equities Are Overvalued

One of the U.K.'s top fund managers of recent years is warning that Europe's equity markets are highly overvalued.

"All evidence points to a troubling growth outlook" in Europe, said Neil Woodford, a 26-year veteran fund manager who left a stellar track record at Invesco IVZ +1.34% Perpetual in April to set up his own firm. Growth in the U.K. is "imbalanced," he added.

Most investors are currently too optimistic, pushing equity valuations way ahead of economic fundamentals, he said in an interview. Europe's equity markets wobbled over the summer due to escalating tensions in the Middle East and conflict in Ukraine, but stock valuations still are near record highs. The Stoxx Europe 600 is up 10.6% in the past 12 months, while the U.K.'s FTSE has gained 4.5%.

Mr. Woodford set up Woodford Investment Management earlier this year after leaving Invesco, the firm he joined in 1988. At Invesco, he recently oversaw around £27 billion ($45 billion) across six funds, scoring returns of about 12% annually in his last five years at the company.

Top U.K. Fund Manager Neil Woodford Says Equities Are Overvalued
Growth in Europe and the U.K. Particularly Worrying

He built a loyal following among investors, some of whom were shocked at his departure. Wealth-management company St. James's Place said in April it was withdrawing an £8 billion mandate from Invesco and would invest some of the money in WIM. Several Invesco employees also moved over to WIM.

Mr. Woodford's first fund at his new venture, the Equity Income Fund, launched in mid-June and attracted £1.6 billion of investment during a two-week initial offer period. The fund mostly buys stakes in U.K.-listed equities, though it also can invest up to 20% in overseas companies. Since the launch, it has grown to around £2.5 billion.

Mr. Woodford said the U.K. in particular is shaped by troubling growth prospects and an excessively lofty currency, he said.

The U.K.'s economy is one of the strongest in the developed world. The Bank of England recently upgraded its national growth forecast to 3.5% from 3.4% for 2014, cementing the view that it will be the first major central bank to raise interest rates from their historic low levels. Many analysts now expect a bump in the benchmark in early 2015. Mr. Woodford cautioned that would be too early, and could stymie the still-fragile recovery. The BOE shouldn't raise interest rates "for a very long time," he said.

The fund manager said that his preferred strategy was to focus on specific company valuations. "I don't see myself investing in an index, but more in individual names," he said.

In July, WIM published a list of the fund's holdings showing that 8.3% of the portfolio was invested in AstraZeneca AZN.LN +1.97% PLC. Another 7.1% of the portfolio is in GlaxoSmithKline GSK.LN +1.34% PLC and 6.2% in British American Tobacco BATS.LN +0.50% PLC. These stocks all have fallen since the WIM fund was launched, with GSK down about 11% in that period. Woodford Investment Management said in its July fund roundup report that the fund's performance was negatively affected by disappointing results from GSK, the fund's second biggest holding. Mr. Woodford's long-term holdings at Invesco featured several major pharmaceutical companies, including GSK.

Mr. Woodford also has invested in smaller health-care and technology companies including Oxford Pharmascience Group PLC, which is listed on London's small-cap AIM index, and Imperial Innovations, which invests in the technology sector, and has a stake in Abzena, a biopharmaceutical services and technology provider that listed on AIM last month.

He stressed his interest in early-stage development companies with particularly strong growth potential and "the ability to be disruptive" to existing players. This month he also bought a stake in unlisted online estate agent purplebricks.com.